Net income 2017
Net income 2018
P/E ratio 2017
P/E ratio 2018
EV / Sales2017
EV / Sales2018
Teligent, Inc. develops, manufactures and markets topical formulations.The company sells generic topical pharmaceutical products under IGI label.It also provides development, formulation, and manufacturing services to the pharmaceutical, over-the-counter and cosmetic markets.The company's products...
Surperformance© ratings of IGI LABORIGI
Trading Rating :
Investor Rating :
Latest news on IGI LABORIGI
TELIGENT : Announces FDA Approval of Triamcinolone Acetonide Cream USP, 0.1%
Teligent, Inc. Announces FDA Approval of Triamcinolone Acetonide Cream USP, 0..
TELIGENT, INC. (NASDAQ : TLGT) Files An 8-K Departure of Directors or Certain Of..
TELIGENT, INC. : Change in Directors or Principal Officers, Other Events, Financ..
Teligent, Inc. Appoints Thomas J. Sabatino, Jr. to Board of Directors
Teligent, Inc. to Present at Morgan Stanley 15th Annual Global Healthcare Con..
TELIGENT : Announces FDA Approval of Clobetasol Propionate Cream USP, 0.05%, Emo..
TELIGENT : Receives Fourth FDA Approval on 2017
Teligent, Inc. Announces FDA Approval of Clobetasol Propionate Cream USP, 0.0..
TELIGENT : reports 2Q loss
Sector news : Pharmaceuticals - NEC
Number of Analysts
Average target price
Spread / Average Target